Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-11

"It is surprising how many shareholders don’t understand the path to commercialisation."

Exactly right Sholtz, I was just thinking the same thing reading through these comments.

For anyone unsure about this go back and rewatch Mr Paterson's most recent presentation where it is clearly laid out....

he talks about valve in valve procedures potentially bringing the company revenue in CY24/25....

beyond that, aortic stenosis, revenues starting in CY26.

Although don't take my word for it, listen to the interview and presentation yourselves.